Early initiation of heparin therapy for treatment of stroke is not only associated with an improved outcome, but also with the risk of hemorrhagic transformation. We compared the efficacy of three unfractionated heparin bolus regimens (0 U/kg, 30 U/kg, or 80 U/kg) in achieving a therapeutic activated partial thromboplastin time over the first 6-hour period in a cohort of 54 patients admitted with transient ischemic attack or stroke. Patients treated with the low bolus dose (30 U/kg) were more often within the therapeutic range for activated partial thromboplastin time at two hours after the initial bolus than patients treated with the other regimens. The percentage of therapeutic activated partial thromboplastin time results within the first six hours of treatment was greater in the group treated with the low bolus dose. Using the low bolus dose may reduce complication rates and improve clinical outcomes in the future clinical trials.
Hirsh J., Raschke R.Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126: 188S-203S.
2.
Caplan LRResolved: heparin may be useful in selected patients with brain ischemia. Stroke. 2003;34:230-231.
3.
Adams HP Jr , del Zoppo G., Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655-1711.
4.
Chamorro A., Busse O., Obach V., et al. The rapid anticoagulation prevents ischemic damage study in acute stroke- final results from the writing committee. Cerebrovasc Dis. 2005;19:402-404.
5.
Duke RJ, Bloch RF, Turpie AG, Trebilcock R., Bayer N.Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. Ann Intern Med. 1986;105:825-828.
6.
Schmidt WP, Heuschmann P., Taeger D., Henningsen H., Buecker-Nott HJ, Berger K.Determinants of IV heparin treatment in patients with ischemic stroke. Neurology. 2004;63:2407-2409.
7.
Al-Sadat A., Sunbulli M., Chaturvedi S.Use of intravenous heparin by North American neurologists: do the data matter?Stroke. 2002;33:1574-1577.
8.
Kang K., Yoon BWSymptomatic intracerebral hematomas in posterior circulation stroke patients anticoagulated with heparin. J Thromb Thrombolysis. 2006;21: 249-255.
9.
Camerlingo M. , Salvi P., Belloni G., Gamba T., Cesana BM, Mamoli A.Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions. Stroke. 2005;36:2415-2420.
10.
Chamorro A. , Vila N., Ascaso C., Blanc R.Heparin in acute stroke with atrial fibrillation: clinical relevance of very early treatment. Arch Neurol. 1999;56:1098-1102.
11.
Cerebral Embolism Study Group.Cardioembolic stroke, early anticoagulation, and brain hemorrhage. Cerebral Embolism Study Group. Arch Intern Med. 1987;147: 636-640.
12.
Hochman JS, Wali AU, Gavrila D., et al. A new regimen for heparin use in acute coronary syndromes. Am Heart J. 1999;138:313-318.
13.
Raschke RA, Reilly BM, Guidry JR, Srinivas S.The weight-based heparin dosing nomogram compared with a ‘‘standard care’’ nomogram. A randomized controlled trial. Ann Intern Med. 1993;119:874-881.
14.
Toth C., Voll C.Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke. Stroke. 2002;33:670-674.
15.
Cerebral Embolism Study Group.Immediate anticoagulation of embolic stroke: a randomized trial. Cerebral Embolism Study Group. Stroke. 1983;14:668-676.
16.
Berge E., Abdelnoor M., Nakstad PH, Sandset PMLow molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet. 2000;355:1205-1210.
17.
Stroke Prevention in Atrial Fibrilllation Investigators.Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet. 1996;348:633-638.
18.
Hylek EM, Go AS, Chang Y., et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 2003;349: 1019-1026.
19.
Cervera A., Justicia C., Reverter JC, Planas AM, Chamorro A.Steady plasma concentration of unfractionated heparin reduces infarct volume and prevents inflammatory damage after transient focal cerebral ischemia in the rat. J Neurosci Res. 2004;77:565-572.
